Find the Perfect Plan for Your Investment Journey
Latest price
52 Week Range
$130.96 - $179.60
Next Earnings Date
May 01 2025
Next Earnings Date
May 01 2025
Latest price
Market Cap | $11.11B |
EV | $24.31B |
Shares Outstanding | 80.06M |
Beta | 1.04 |
Analyst Rating | HOLD |
Analyst Target Price | $164.57 |
P/E 2025E | 12.59x |
P/Revenue 2025E | 0.83x |
Revenue | 3.30% |
EPS | 2.00% |
Operating Cash Flow | 1.60% |
Free Cash Flow | 4.40% |
Revenue | 4.20% |
EPS | 14.20% |
Operating Cash Flow | 1.70% |
Free Cash Flow | -7.10% |
Gross Margin 2025E | 32.16% |
Net Profit Margin 2025E | 6.40% |
ROE 2025E | 330.28% |
ROCE 2024 | 159.08% |
DPS 2025E | $1.67 |
Payout Ratio 2025E | 15.14% |
Div. Yield 2025E | 1.20% |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
DaVita Inc.
DVA
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Rodriguez, Javier
Employees
76,000
Website
www.davita.comIPO Date
1995-10-31
Headquarters
2000 16th Street, Denver, Colorado, 80202, United States
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved